Interaction Between Tumor Suppressor Adenomatous Polyposis Coli and Topoisomerase IIalpha: Implication for the G2/M Transition

Overview

Journal Mol Biol Cell

Specialties Cell Biology
Molecular Biology

Date 2008 Jul 18

PMID 18632987

Citations 18

Authors

Yang Wang

Yoshiaki Azuma

David Moore

Neil Osheroff

Kristi L Neufeld

Affiliations

Soon will be listed here.

Abstract

The tumor suppressor adenomatous polyposis coli (APC) is implicated in regulating multiple stages of the cell cycle. APC participation in G1/S is attributed to its recognized role in Wnt signaling. APC function in the G2/M transition is less well established. To identify novel protein partners of APC that regulate the G2/M transition, APC was immunoprecipitated from colon cell lysates and associated proteins were analyzed by matrix-assisted laser desorption ionization/time of flight (MALDI-TOF). Topoisomerase IIalpha (topo IIalpha) was identified as a potential binding partner of APC. Topo IIalpha is a critical regulator of G2/M transition. Evidence supporting an interaction between endogenous APC and topo IIalpha was obtained by coimmunoprecipitation, colocalization, and Förster resonance energy transfer (FRET). The 15-amino acid repeat region of APC (M2-APC) interacted with topo IIalpha when expressed as a green fluorescent protein (GFP)-fusion protein in vivo. Although lacking defined nuclear localization signals (NLS) M2-APC predominantly localized to the nucleus. Furthermore, cells expressing M2-APC displayed condensed or fragmented nuclei, and they were arrested in the G2 phase of the cell cycle. Although M2-APC contains a beta-catenin binding domain, biochemical studies failed to implicate beta-catenin in the observed phenotype. Finally, purified recombinant M2-APC enhanced topo IIalpha activity in vitro. Together, these data support a novel role for APC in the G2/M transition, potentially through association with topo IIalpha.

Citing Articles

Alpha Mangostin and Cisplatin as Modulators of Exosomal Interaction of Ovarian Cancer Cell with Fibroblasts.

Borzdzilowska P, Bednarek I Int J Mol Sci. 2022; 23(16).

PMID: 36012171 PMC: 9408324. DOI: 10.3390/ijms23168913.

coli in cancer and therapeutic implications.

Noe O, Filipiak L, Royfman R, Campbell A, Lin L, Hamouda D Oncol Rev. 2021; 15(1):534.

PMID: 34267890 PMC: 8256374. DOI: 10.4081/oncol.2021.534.

The Role of Noncoding RNAs in the Regulation of Anoikis and Anchorage-Independent Growth in Cancer.

Lee H, Son S, Moeng S, Choi S, Park J Int J Mol Sci. 2021; 22(2).

PMID: 33435156 PMC: 7827914. DOI: 10.3390/ijms22020627.

Wnt-Independent and Wnt-Dependent Effects of APC Loss on the Chemotherapeutic Response.

Stefanski C, Prosperi J Int J Mol Sci. 2020; 21(21).

PMID: 33105836 PMC: 7660076. DOI: 10.3390/ijms21217844.

APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells.

Stefanski C, Keffler K, McClintock S, Milac L, Prosperi J Neoplasia. 2019; 21(12):1143-1150.

PMID: 31759252 PMC: 6872841. DOI: 10.1016/j.neo.2019.09.002.

References

Gasser S, Laroche T, Falquet J, BOY DE LA TOUR E, Laemmli U . Metaphase chromosome structure. Involvement of topoisomerase II. J Mol Biol. 1986; 188(4):613-29. DOI: 10.1016/s0022-2836(86)80010-9. View

Worland S, Wang J . Inducible overexpression, purification, and active site mapping of DNA topoisomerase II from the yeast Saccharomyces cerevisiae. J Biol Chem. 1989; 264(8):4412-6. View

Downes C, Clarke D, Mullinger A, Gimenez-Abian J, Creighton A, Johnson R . A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells/. Nature. 1994; 372(6505):467-70. DOI: 10.1038/372467a0. View

Earnshaw W, Heck M . Localization of topoisomerase II in mitotic chromosomes. J Cell Biol. 1985; 100(5):1716-25. PMC: 2113864. DOI: 10.1083/jcb.100.5.1716. View

Bhat U, Raychaudhuri P, Beck W . Functional interaction between human topoisomerase IIalpha and retinoblastoma protein. Proc Natl Acad Sci U S A. 1999; 96(14):7859-64. PMC: 22152. DOI: 10.1073/pnas.96.14.7859. View

Aoki K, Aoki M, Sugai M, Harada N, Miyoshi H, Tsukamoto T . Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells. Oncogene. 2006; 26(24):3511-20. DOI: 10.1038/sj.onc.1210141. View

Lou Z, Minter-Dykhouse K, Chen J . BRCA1 participates in DNA decatenation. Nat Struct Mol Biol. 2005; 12(7):589-93. DOI: 10.1038/nsmb953. View

Kingma P, Greider C, Osheroff N . Spontaneous DNA lesions poison human topoisomerase IIalpha and stimulate cleavage proximal to leukemic 11q23 chromosomal breakpoints. Biochemistry. 1997; 36(20):5934-9. DOI: 10.1021/bi970507v. View

Fortune J, Osheroff N . Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice. Prog Nucleic Acid Res Mol Biol. 2000; 64:221-53. DOI: 10.1016/s0079-6603(00)64006-0. View

10.

Kinzler K, Vogelstein B . Lessons from hereditary colorectal cancer. Cell. 1996; 87(2):159-70. DOI: 10.1016/s0092-8674(00)81333-1. View

11.

Watanabe T, Wang S, Noritake J, Sato K, Fukata M, Takefuji M . Interaction with IQGAP1 links APC to Rac1, Cdc42, and actin filaments during cell polarization and migration. Dev Cell. 2004; 7(6):871-83. DOI: 10.1016/j.devcel.2004.10.017. View

12.

ISHIDATE T, Matsumine A, Toyoshima K, Akiyama T . The APC-hDLG complex negatively regulates cell cycle progression from the G0/G1 to S phase. Oncogene. 2000; 19(3):365-72. DOI: 10.1038/sj.onc.1203309. View

13.

Fortune J, Osheroff N . Topoisomerase II-catalyzed relaxation and catenation of plasmid DNA. Methods Mol Biol. 2000; 95:275-81. DOI: 10.1385/1-59259-057-8:275. View

14.

Heinen C, Goss K, Cornelius J, Babcock G, Knudsen E, Kowalik T . The APC tumor suppressor controls entry into S-phase through its ability to regulate the cyclin D/RB pathway. Gastroenterology. 2002; 123(3):751-63. DOI: 10.1053/gast.2002.35382. View

15.

Sierra J, Yoshida T, Joazeiro C, Jones K . The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev. 2006; 20(5):586-600. PMC: 1410807. DOI: 10.1101/gad.1385806. View

16.

Murphy K, Nielson K, Albertine K . Defining a molecularly normal colon. J Histochem Cytochem. 2001; 49(5):667-8. DOI: 10.1177/002215540104900516. View

17.

Heck M, Hittelman W, Earnshaw W . Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proc Natl Acad Sci U S A. 1988; 85(4):1086-90. PMC: 279709. DOI: 10.1073/pnas.85.4.1086. View

18.

Galea M, Eleftheriou A, Henderson B . ARM domain-dependent nuclear import of adenomatous polyposis coli protein is stimulated by the B56 alpha subunit of protein phosphatase 2A. J Biol Chem. 2001; 276(49):45833-9. DOI: 10.1074/jbc.M107149200. View

19.

Yamane K, Chen J, Kinsella T . Both DNA topoisomerase II-binding protein 1 and BRCA1 regulate the G2-M cell cycle checkpoint. Cancer Res. 2003; 63(12):3049-53. View

20.

Wang J . Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol. 2002; 3(6):430-40. DOI: 10.1038/nrm831. View